Skip to main content
. Author manuscript; available in PMC: 2020 Sep 29.
Published in final edited form as: Arthritis Rheumatol. 2016 Sep;68(9):2283–2289. doi: 10.1002/art.39773

Table 1.

Characteristics of the IgG4-RD patients according to history of malignancy*

Variable All (n = 125) No history of malignancy (n = 105) History of malignancy (n = 20) P
Age at IgG4-RD onset, mean ± SD years 50.3 ± 14.9 48.5 ± 14.3 59.8 ± 14.6 0.002
Male sex 76 (60.8) 61 (58.1) 15 (75) 0.2
White race 96 (77) 77 (73) 19 (95) 0.04
Disease duration prior to evaluation, median (IQR) years 2 (1–6) 2.5 (1–6) 1 (0.5–4.5) 0.14
No. of involved organs, mean ± SD 2.3 ± 1.3 2.3 ± 1.4 2.4 ± 1.1 0.7
Serum IgG4, median (IQR) mg/dl 140 (55.1–408) 121 (49.8–319) 407.5 (139–655) 0.03
Organ involvement
 Submandibular gland 35 (28) 30 (29) 4 (20) 0.6
 Lymph nodes 34 (27) 29 (28) 5 (25) 1
 Orbit 28 (22) 23 (22) 4 (20) 1
 Pancreas 24 (19) 20 (19) 4 (20) 1
 Retroperitoneum 25 (20) 21 (20) 4 (20) 1
*

Except where indicated otherwise, values are the number (%). IgG4-RD = IgG4-related disease; IQR = interquartile range.

Among patients with active disease at the initial visit.